Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert M Califf

Showing results (91-100 of 770) with videos related to

Pageof 77
Sort By:
Journal of the American College of Cardiology|December 19, 2006
Late ischemic events after clopidogrel cessation following drug-eluting stenting: should we be worried?Robert A Harrington, Robert M Califf
JAMA|December 29, 2022
The Need for a Smoking Cessation "Care Package"Robert M Califf, Brian A King
JAMA|December 2, 2022
Over-the-counter Hearing Aids: From Research to Policy to PracticeDebara L Tucci, Robert M Califf
Heart Rhythm|August 8, 2013
Postmarket surveillance and returned product analysis: success but not transparencyJonathan P Piccini, Robert M Califf
European Heart Journal|November 30, 2018
Standardized classification and framework for reporting and interpreting medication non-adherence in clinical trialsFortunato F Senatore, Robert M Califf
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 15, 2018
Individual risk prediction using data beyond the medical clinicRobert M Califf, Frank E Harrell
Journal of the American College of Cardiology|April 9, 2025
Improving Medical Device Safety Surveillance: Bridging Capability and CommitmentLesley H Curtis, Robert M Califf
Circulation Research|April 24, 2020
Reimagining What We Measure in Atherosclerosis-a "Phenotype Stack"Calum A MacRae, Robert M Califf
Pharmacoepidemiology and Drug Safety|July 26, 2008
The balance of benefit and safety of rosiglitazone: important lessons for our system of drug development and postmarketing assessmentRobert M Califf, Judith M Kramer
Circulation|May 26, 2010
There is a role for industry-sponsored education in cardiologyRobert A Harrington, Robert M Califf
Pageof 77

Showing results (91-100 of 770) with videos related to

Sort By:
Pageof 77
Journal of the American College of Cardiology|December 19, 2006
Late ischemic events after clopidogrel cessation following drug-eluting stenting: should we be worried?Robert A Harrington, Robert M Califf
JAMA|December 29, 2022
The Need for a Smoking Cessation "Care Package"Robert M Califf, Brian A King
JAMA|December 2, 2022
Over-the-counter Hearing Aids: From Research to Policy to PracticeDebara L Tucci, Robert M Califf
Heart Rhythm|August 8, 2013
Postmarket surveillance and returned product analysis: success but not transparencyJonathan P Piccini, Robert M Califf
European Heart Journal|November 30, 2018
Standardized classification and framework for reporting and interpreting medication non-adherence in clinical trialsFortunato F Senatore, Robert M Califf
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 15, 2018
Individual risk prediction using data beyond the medical clinicRobert M Califf, Frank E Harrell
Journal of the American College of Cardiology|April 9, 2025
Improving Medical Device Safety Surveillance: Bridging Capability and CommitmentLesley H Curtis, Robert M Califf
Circulation Research|April 24, 2020
Reimagining What We Measure in Atherosclerosis-a "Phenotype Stack"Calum A MacRae, Robert M Califf
Pharmacoepidemiology and Drug Safety|July 26, 2008
The balance of benefit and safety of rosiglitazone: important lessons for our system of drug development and postmarketing assessmentRobert M Califf, Judith M Kramer
Circulation|May 26, 2010
There is a role for industry-sponsored education in cardiologyRobert A Harrington, Robert M Califf
Pageof 77